Good morning. We have a busy week ahead with 17 companies (11 from the Health Care sector) planned to go public this week (01 Feb - 05 Feb)
LDI loanDepot 2010
Financial Services • 15,000,000 shares • $19.00 - $21.00 • NYSE
loanDepot is an independent retail mortgage lender that provides residential loans, refinance loans, and personal loan products nationwide.
Notify me when $LDI goes public
The expected IPO date is Thursday, February 4th, 2021
VOR Vor Biopharma 2016
Health Care • 8,823,530 shares • $16.00 - $18.00 • Nasdaq
Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer. It is focused on developing technologies that can enable selective targeting of cancer cells without impacting normal cells. Cell surface-targeted immunotherapies, such as bispecific antibodies, antibody-drug conjugates, and chimeric antigen receptor (CAR) Tcells, generally target both cancer and normal cells, causing substantial toxicities and limiting their potential.
Notify me when $VOR goes public
IMCR Immunocore Holdings 2008
Health Care • 8,333,333 shares • $23.00 - $25.00 • Nasdaq
Immunocore is a focused on the discovery and development of novel T cell receptor-based drugs to treat diseases with a high unmet need, including cancer and viral disease.
Notify me when $IMCR goes public
SNSE Sensei Biotherapeutics undefined
Health Care • 5,885,000 shares • $16.00 - $18.00 • Nasdaq
Sensei Biotherapeutics is a clinical-stage biotechnology company specializing in the field of next-generation cancer immunotherapies. The company developing novel biologics therapies targeting key components of the immune system for the treatment of cancers of unmet need.
Notify me when $SNSE goes public
LABP Landos Biopharma 2017
Health Care • 6,250,000 shares • $15.00 - $17.00 • Nasdaq
Landos Biopharma is a developer of an oral first-in-class therapeutics designed to target autoimmune diseases.The company's therapeutics are novel, locally-acting small molecules targeting inflammatory bowel disease (IBD), crohn's disease (CD) and ulcerative colitis (UC), enabling healthcare providers to cure their patients.
Notify me when $LABP goes public
The expected IPO date is Thursday, February 4th, 2021
EVAX Evaxion Biotech 2008
Health Care • 2,750,000 shares • $10.00 - $12.00 • Nasdaq
Evaxion Biotech is devoted to the discovery and development of vaccines against cancer and infectious diseases.
Notify me when $EVAX goes public
TERN Terns Pharmaceuticals 2016
Health Care • 6,250,000 shares • $15.00 - $17.00 • Nasdaq
Terns Pharmaceuticals is a global biopharmaceutical company committed to discovering and developing molecularly-targeted, oral, small molecule drugs to treat liver disease and cancer.
Notify me when $TERN goes public
SANA Sana Biotechnology 2018
Health Care • 15,000,000 shares • $20.00 - $23.00 • Nasdaq
Sana Biotechnology focuses on creating and delivering engineered cells as medicine for patients. Recent scientific advances make it possible to reprogram cells in the body or replace damaged cells and tissues, creating a new class of medicines to treat a broad array of diseases.
Notify me when $SANA goes public
The expected IPO date is Thursday, February 4th, 2021
BOLT Bolt Biotherapeutics 2015
Health Care • 8,825,000 shares • $16.00 - $18.00 • Nasdaq
Bolt Biotherapeutics is a biotechnology company that develops a platform for cancer immunotherapy. Its platform, Boltbody, is a cancer immunotherapy that consists of immune-stimulating antibody conjugates.
Notify me when $BOLT goes public
ANGN Angion Biomedica 1998
Health Care • 5,000,000 shares • $14.00 - $16.00 • Nasdaq
Angion Biomedica is a clinical-stage organ restoration biopharmaceutical company focused on renal disease. Its investigational drug BB3 is entering phase 3 for delayed graft function following kidney transplant and phase 2 for acute kidney injury following open-heart surgery using cardiopulmonary bypass.
Notify me when $ANGN goes public
LHDX Lucira Health 2013
Health Care • 7,812,500 shares • $15.00 - $17.00 • Nasdaq
Lucira Health develops a new class of professional and home-health solutions to help illuminate and elucidate health status to expedite decision-making and treatment. The company's at-home test kit is well suited for home use and the molecular nucleic acid amplification technology is adaptable to COVID-19 detection.
Notify me when $LHDX goes public
PHVS Pharvaris 2015
Health Care • 6,950,000 shares • $17.00 - $19.00 • Nasdaq
Pharvaris is a clinical-stage company focused on bringing an oral bradykinin B2 receptor antagonist to patients. By targeting this clinically proven therapeutic target with novel small molecules, we are progressing new alternatives to injected therapies for all sub-types of hereditary angioedema (HAE) and other B2 receptor-mediated indications.PHA121, Pharvaris’ lead drug candidate, is a novel and potent small-molecule bradykinin B2 receptor antagonist currently under Phase 1 clinical study.
Notify me when $PHVS goes public
UGRO urban-gro 2013
Industrial Products • 4,285,714 shares • $10.50 • Nasdaq
urban-gro was founded on the principle of supplying not only the very best in professional cultivation product solutions, but also the knowledge and education required to maximize plant health and economic yield.
Notify me when $UGRO goes public
The expected IPO date is Monday, February 1st, 2021
ATC Atotech 1993
Materials • 34,146,000 shares • $19.00 - $22.00 • NYSE
Atotech is an international speciality chemicals company, a subsidiary of the French oil and gas company Total S.A.
Notify me when $ATC goes public
The expected IPO date is Thursday, February 4th, 2021
ONTF ON24 1998
Software & Tech Services • 8,600,977 shares • $45.00 - $50.00 • NYSE
ON24 is the global leader in webinar-based marketing solutions that drive demand generation and customer engagement. Its patented cloud-based platform features an interactive and immersive user interface and industry-leading webinar analytics for events, campaigns and benchmarking.
Notify me when $ONTF goes public
The expected IPO date is Wednesday, February 3rd, 2021
TIXT TELUS International 1990
Software & Tech Services • 33,333,333 shares • $23.00 - $25.00 • NYSE
TELUS International designs, builds and delivers next-generation digital solutions to enhance the customer experience.
Notify me when $TIXT goes public
The expected IPO date is Wednesday, February 3rd, 2021
MULG Muliang Viagoo Technology 2014
Software & Tech Services • 10,000,000 shares • $4.00 • Nasdaq
A Chinese manufacturer and distributor of organic fertilizer and agricultural products.
Notify me when $MULG goes public
The expected IPO date is Wednesday, February 3rd, 2021
If you have any questions or would like to see more information, just hit the reply button.
And please share it with friends using the links below:
|